SARS CoV 2 Clinical Trials
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
M
Completed
- SARS-CoV-2
- Covid19
- Home-based SARS-CoV-2 test kit
- Pablo, Montana
- +1 more
2022-04-06
Apr 6, 2022B
Completed
- Sars-CoV-2
- Covid19
- Irvine, California
- +34 more
2022-04-01
Apr 1, 2022M
Active, not recruiting
- SARS-CoV-2
- mRNA-1283
- +3 more
- Phoenix, Arizona
- +16 more
2022-03-25
Mar 25, 2022S
Recruiting
- SARS-CoV-2
- Sodium Chloride
- +4 more
- New York, New YorkIcahn School of Medicine at Mount Sinai
2022-04-04
Apr 4, 2022A
Active, not recruiting
- SARS-CoV-2
- +2 more
- MOLECULAR HYDROGEN
- PLACEBO MAGNESIUM
- Grenoble, France
- +2 more
2022-04-04
Apr 4, 2022M
Recruiting
- SARS-CoV-2
- mRNA-1273
- Placebo
- Banning, California
- +45 more
2022-03-22
Mar 22, 2022S
Recruiting
- SARS-CoV-2
- Cohort 1 VACCINE RNA MCTI CIMATEC HDT (HDT-301) vaccine
- +3 more
- Salvador, Bahia, BrazilHospital da Bahia
2022-03-23
Mar 23, 2022U
Completed
- COVID
- +3 more
- Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG)
- +2 more
- Colorado Springs, Colorado
- +38 more
2022-03-31
Mar 31, 2022V
Withdrawn
- Covid-19
- +2 more
- UB-612
- Placebo
- (no location specified)
2022-03-21
Mar 21, 2022A
Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults
Active, not recruiting
- COVID-19
- SARS-CoV-2
- AZD1222
- Placebo
- Phoenix, Arizona
- +83 more
2022-03-31
Mar 31, 2022C
Comparison of EPM-IX to Currently Used Specimen Transportation and Extraction Devices ( CGI-EPM-IX )
Recruiting
- SARS-CoV-2
- Enhanced Preservation Media (EPM-IX)
- Chicago, IllinoisUroPartners Urology Group
2022-03-18
Mar 18, 2022M
Recruiting
- SARS-CoV-2
- mRNA-1273
- Atlanta, Georgia
- +1 more
2022-03-10
Mar 10, 2022Z
Recruiting
- COVID-19
- +3 more
- Roskilde, Region Sjaelland, DenmarkZealand University Hospital
2022-03-08
Mar 8, 2022C
Completed
- Coronavirus
- +3 more
- CVnCoV 6 μg
- +4 more
- Panama city, Panama
- +1 more
2022-03-09
Mar 9, 2022B
Completed
- COVID-19
- SARS-CoV-2
- PEP flute
- Frederiksberg, DenmarkResearch Unit for Dietary Studies at the Parker Institute, Bispe
2022-03-21
Mar 21, 2022M
Recruiting
- SARS-CoV-2
- mRNA-1273.211
- +4 more
- Sacramento, California
- +22 more
2022-03-04
Mar 4, 2022B
Not yet recruiting
- Sars-cov-2
- Xagrotin
- Green tea
- Sulaymaniyah, IraqDirectorate of health of Sulaimani, Iraq -KRG
2022-03-02
Mar 2, 2022C
Recruiting
- Covid19
- SARS-CoV-2
- Sampling by venipuncture (and eventually by nasopharyngeal swab)
- Orléans, FranceCentre Hospitalier Régional d'Orléans, France
2022-03-16
Mar 16, 2022H
Recruiting
- Allergic Rhinitis
- +2 more
- There is no intervention in this study.
- Wuhan, Hubei, ChinaDepartment of ENT, Tongji Hospital, Tongji Medical College, Huaz
2022-03-16
Mar 16, 2022A
Not yet recruiting
- SARS-CoV-2
- Long Beach, California
- +19 more
2022-03-11
Mar 11, 2022U
Not yet recruiting
- Lung Transplant Recipient
- +2 more
- mRNA-1273 (Moderna COVID-19 vaccine)
- (no location specified)
2022-03-05
Mar 5, 2022R
Active, not recruiting
- COVID-19
- +3 more
- Rejuveinix (RJX) Active Comparator
- Placebo Comparator
- Houston, Texas
- +2 more
2022-03-14
Mar 14, 2022A
Active, not recruiting
- COVID-19
- SARS-CoV-2
- AZD1222
- AZD2816
- Brasilia, Brazil
- +34 more
2022-03-11
Mar 11, 2022B
Active, not recruiting
- SARS-CoV-2
- BNT162b2
- Placebo
- Jiangsu, ChinaJiangsu Provincial Center for Disease Control and Prevention
2022-03-10
Mar 10, 2022S
Terminated
- SARS-CoV-2
- Emapalumab
- Anakinra
- Saint Paul, Minnesota
- +11 more
2022-03-03
Mar 3, 2022